Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
3,576 results
  • Prevention of breast cancer. [Journal Article]
  • MJMed J Aust 2016 Nov 21; 205(10):475-479
  • Olver IN
  • Modifiable lifestyle factors may reduce the risk of developing breast cancer. Obesity is associated particularly with post-menopausal breast cancer. Diet is important, and exercise equivalent to runn...
  • Metabolism and toxicological implications of commonly used chemopreventive drugs against breast cancer/carcinogenesis. [Journal Article]
  • CDCurr Drug Metab 2016 Nov 16
  • Muhammad A, Ibrahim MA, … Mohammed HA
  • CONCLUSIONS: The aromatase inhibitors seem to be most appropriate when it comes to application by virtue of their metabolic functions and fates. The reason is that raloxifene and tamoxifen are not the ideal drugs to reduce the incidence of primary invasive breast cancer because their safety and efficacy don't reach the desired optimal agent level. However, adequate care should be taken while prescribing, as well as during and after treatment with constant close monitoring of patients for any possible biochemical and clinical manifestations vis-à-vis the issue of pharmacogenetics.
New Search Next